Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03789552 |
|
Recruitment Status : Unknown
Verified April 2020 by Tasly Pharmaceuticals, Inc..
Recruitment status was: Recruiting
First Posted : December 28, 2018
Last Update Posted : January 13, 2021
|
Sponsor:
Tasly Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Tasly Pharmaceuticals, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Estimated Primary Completion Date : | April 1, 2023 |
| Estimated Study Completion Date : | September 1, 2023 |